Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Skinny Tonic (ST) aims to change the traditional soft drink market by creating 100% natural, zero-sugar, zero-calorie soft drinks. The company raised £1.8 million in its first Seedrs raise in January 2020. It also raised £1.75 million in conjunction with the UK Future Fund and received the Food Matters Award for 'New drink product of the year'. ST also launched four flavours into 27 Booths stores in June 2020. It will use the investment to pioneer New Product Development (NPD), achieve British Retail Consortium (BRC) accreditation, continue to invest in staff training and recruitment, launch its fully automated canning and bottling facility, and grow the business across different verticals.
days to go:
Expired
investment:
£2,433,839
Tribal Sports Nutrition (TSN) uses the revitalising properties of the Baobab fruit to create energy smoothies. TSN claims that its smoothies are less concentrated than other sports nutrition brands, are 100% organic, and easy on the stomach. The company also incorporates vitamin C, antioxidants, fibre, and electrolytes into the smoothies to make it the on-the-go snack for active lifestyle consumers. TSN asserts that its baobab ingredient is wild-harvested by cooperatives in Africa, bringing income to people and preserving the local ecology. The company received a certification from the Organic Food Federation (OFF) and aims to achieve B Corp status. TSN's products have been listed in Sainsbury's and on Amazon. It will use the investment to double its existing product offering in 2021 and launch hydration, plant protein recovery products, and Baobab energy snacks.
days to go:
Expired
investment:
£421,647
Licklist is a social marketplace for nightlife. It is the only website that allows users to keep up to date with the latest news, reviews and events across the UK. For nightclubs and bars, they provide innovative tools for the users to fill a venue both cost-effectively and efficiently. They have a directory of over 6,000 venues to the community on their platform and operate the UK's largest photography agency with over 1,200 photographers, covering over 2,000 events per month and uploading over 50,000 photos per week. Till now, they have more than 600,000 registered users and they are growing by 10k-15k new users per month with positive cash-flow. With the proceeds, they will build a sales team, spend more on marketing and technology.
days to go:
Expired
investment:
£140,727
Artfinder is the art world's first certified B corporation that is on a mission to create a world where art benefits everyone. Operating in the $55 billion+ wall décor and online art market, the company is backed by Wellington Partners, and private investors in the UK, US and Switzerland. It has 60,000 customers, 6,000 artists and a collection of 470,000 artworks. The company believes in establishing direct contact with artists to select or commission work and negotiate prices. Customers have rated the company highly with 4.8+ Trustpilot reviews. The company will use the investment to supercharge its growth, grow its team and improve its platform.
days to go:
Expired
investment:
£834,056
Clooper is a property management platform. The company argues that 86% of private landlords in the UK manage their properties themselves, with many finding it time-consuming and stressful. Clooper seeks to solve this problem with a property management platform that connects landlords, tenants, trade services, and homeowners to facilitate easy transactions between them. It aims to be a significant contender in the £11 billion property management platform. The company points out that Paul Rothwell of Empire, a large residential landlord in England, has pledged £200,000 of investment to the company. Clooper aims to make move-ins quicker, repairs faster, and payments easier in the wake of Covid-19 which is fuelling the adoption of online services in the UK. The company will use the investment to hire key recruits, operationalise mobile apps, boost marketing, and enhance sales and operations.
days to go:
Expired
investment:
£409,847
